Literature DB >> 21951282

Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint.

P Silva1, J Barbosa, A V Nascimento, J Faria, R Reis, H Bousbaa.   

Abstract

Accurate chromosome segregation relies on activity of the spindle assembly checkpoint, a surveillance mechanism that prevents premature anaphase onset until all chromosomes are properly attached to the mitotic spindle apparatus and aligned at the metaphase plate. Defects in this mechanism contribute to chromosome instability and aneuploidy, a hallmark of malignant cells. Here, we review the molecular mechanisms of activation and silencing of the spindle assembly checkpoint and its relationship to tumourigenesis.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21951282      PMCID: PMC6496767          DOI: 10.1111/j.1365-2184.2011.00767.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  94 in total

Review 1.  Attachment and tension in the spindle assembly checkpoint.

Authors:  Jun Zhou; Joyce Yao; Harish C Joshi
Journal:  J Cell Sci       Date:  2002-09-15       Impact factor: 5.285

2.  Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint.

Authors:  Zhanyun Tang; Hongjun Shu; Dilhan Oncel; She Chen; Hongtao Yu
Journal:  Mol Cell       Date:  2004-11-05       Impact factor: 17.970

Review 3.  Rod-Zw10-Zwilch: a key player in the spindle checkpoint.

Authors:  Roger Karess
Journal:  Trends Cell Biol       Date:  2005-07       Impact factor: 20.808

4.  The conserved KMN network constitutes the core microtubule-binding site of the kinetochore.

Authors:  Iain M Cheeseman; Joshua S Chappie; Elizabeth M Wilson-Kubalek; Arshad Desai
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

5.  Dynein light intermediate chain 1 is required for progress through the spindle assembly checkpoint.

Authors:  Mylavarapu V S Sivaram; Thomas L Wadzinski; Sambra D Redick; Tapas Manna; Stephen J Doxsey
Journal:  EMBO J       Date:  2009-02-19       Impact factor: 11.598

6.  Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs.

Authors:  Karen E Gascoigne; Stephen S Taylor
Journal:  Cancer Cell       Date:  2008-07-24       Impact factor: 31.743

7.  A small-molecule inhibitor of Mps1 blocks the spindle-checkpoint response to a lack of tension on mitotic chromosomes.

Authors:  Russell K Dorer; Sheng Zhong; John A Tallarico; Wing Hung Wong; Timothy J Mitchison; Andrew W Murray
Journal:  Curr Biol       Date:  2005-06-07       Impact factor: 10.834

Review 8.  On the road to cancer: aneuploidy and the mitotic checkpoint.

Authors:  Geert J P L Kops; Beth A A Weaver; Don W Cleveland
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

9.  Evidence that the Ipl1-Sli15 (Aurora kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections.

Authors:  Tomoyuki U Tanaka; Najma Rachidi; Carsten Janke; Gislene Pereira; Marta Galova; Elmar Schiebel; Michael J R Stark; Kim Nasmyth
Journal:  Cell       Date:  2002-02-08       Impact factor: 41.582

10.  Stable kinetochore-microtubule interactions depend on the Ska complex and its new component Ska3/C13Orf3.

Authors:  Thomas N Gaitanos; Anna Santamaria; A Arockia Jeyaprakash; Bin Wang; Elena Conti; Erich A Nigg
Journal:  EMBO J       Date:  2009-04-09       Impact factor: 11.598

View more
  25 in total

1.  Overexpression of Fbxo6 inactivates spindle checkpoint by interacting with Mad2 and BubR1.

Authors:  Han-Zhang Xu; Zhuo-Qun Wang; Hui-Zhuang Shan; Li Zhou; Li Yang; Hu Lei; Bin Liu; Ying-Li Wu
Journal:  Cell Cycle       Date:  2018-12-18       Impact factor: 4.534

2.  Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction.

Authors:  Despoina Sakellariou; Maria Chiourea; Christina Raftopoulou; Sarantis Gagos
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

Review 3.  Genetic instability in budding and fission yeast-sources and mechanisms.

Authors:  Adrianna Skoneczna; Aneta Kaniak; Marek Skoneczny
Journal:  FEMS Microbiol Rev       Date:  2015-06-24       Impact factor: 16.408

4.  Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.

Authors:  Ana Vanessa Nascimento; Florence Gattacceca; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Nanomedicine (Lond)       Date:  2016-03-16       Impact factor: 5.307

Review 5.  Improving Homology-Directed Repair in Genome Editing Experiments by Influencing the Cell Cycle.

Authors:  Svetlana A Smirnikhina; Milyausha I Zaynitdinova; Vasilina A Sergeeva; Alexander V Lavrov
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

6.  Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems.

Authors:  Bárbara Pinto; Pedro Novais; Ana C Henriques; Juliana Carvalho-Tavares; Patrícia M A Silva; Hassan Bousbaa
Journal:  Pharmaceutics       Date:  2022-06-06       Impact factor: 6.525

7.  Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.

Authors:  Ana Vanessa Nascimento; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Acta Biomater       Date:  2016-09-30       Impact factor: 8.947

Review 8.  Mitotic exit and separation of mother and daughter cells.

Authors:  Eric L Weiss
Journal:  Genetics       Date:  2012-12       Impact factor: 4.562

9.  Methods for Chromosome Doubling.

Authors:  Mehran E Shariatpanahi; Mohsen Niazian; Behzad Ahmadi
Journal:  Methods Mol Biol       Date:  2021

10.  Cycles and the qualitative evolution of chemical systems.

Authors:  Peter Kreyssig; Gabi Escuela; Bryan Reynaert; Tomas Veloz; Bashar Ibrahim; Peter Dittrich
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.